Posts

Posted on

Night splints for plantar fasciitis

Night splints are a useful conservative treatment for plantar fasciitis, especially for patients who wake with strong first-step pain, but their benefit is usually greatest in the short term rather than as a stand-alone long-term cure.

Plantar fasciitis is one of the most common causes of plantar heel pain in active and sedentary adults, and it typically presents with sharp pain on the first steps in the morning or after periods of rest. Night splints are designed to reduce that familiar morning pain by holding the ankle in dorsiflexion and keeping the plantar fascia under a gentle stretch overnight. In practice, they are most often used for patients whose symptoms persist despite basic measures such as stretching, activity adjustment, and supportive shoes.

How Night Splints Work

The underlying idea is simple: during sleep, the foot tends to rest in plantarflexion, which allows the plantar fascia and calf complex to tighten. When the patient stands up in the morning, that shortened tissue is suddenly loaded, contributing to the classic “first-step” pain of plantar fasciitis. By maintaining a sustained stretch through the night, the splint may reduce this tightening and make morning steps less painful.

This mechanism also makes night splints conceptually similar to prolonged stretching, but with the advantage that the stretch is passive and occurs during rest. Some splints are bulkier posterior boot designs, while others are lower-profile dorsal strap devices; both aim to hold the ankle in dorsiflexion, but comfort and adherence can differ. The best device is often the one the patient will actually tolerate consistently.

Evidence and Effectiveness

The evidence supports night splints as a reasonable option, but not as a guaranteed solution. A clinical trial reported significant short-term relief when a night splint was added to conservative management, although it did not reduce recurrence at two years. A separate review in primary care literature noted that custom-made night splints may help, while prefabricated options had less convincing benefit. More recent clinical practice guidance recommends a 1- to 3-month night splint program for patients who consistently have first-step morning pain.

That said, the literature is not uniformly enthusiastic. Some reports suggest night splints improve symptoms mainly while they are being used, with less clear long-term superiority over exercise-based care alone. For an academic essay, this tension is important: night splints are evidence-informed, but their role is best described as adjunctive and symptom-focused rather than curative.

Clinical Use

Night splints are usually prescribed for patients with persistent plantar fasciitis, especially those with pronounced morning pain or symptoms lasting more than several weeks. They are commonly introduced after or alongside stretching programs, calf flexibility work, and advice on reducing aggravating loads. The usual course is about 1 to 3 months, with reassessment if symptoms fail to improve.

Comfort and adherence matter a great deal. Instructions for use commonly emphasize adjusting straps so the device is snug but not overly tight, and reducing tension if numbness, tingling, or other discomfort occurs. Some clinicians advise a gradual break-in period, because immediate overnight wear may be uncomfortable for some patients. If used poorly or inconsistently, even a theoretically effective treatment may fail.

Advantages and Limitations

The main advantages of night splints are their non-invasive nature, low cost relative to procedural interventions, and ability to target the troublesome morning pain pattern. They can be especially attractive for patients who want to avoid injections or surgery while still doing something active about their symptoms. Because they work passively, they may also suit patients who struggle to keep up with frequent stretching routines.

The limitations are equally important. Night splints can be uncomfortable, interfere with sleep, and reduce adherence, particularly if the splint is bulky or tightly fitted. Evidence also suggests that their effect may be temporary, and they should not be presented as a definitive solution for all cases of plantar fasciitis. In severe or atypical cases, clinicians must also consider other diagnoses such as stress injury, nerve entrapment, or systemic inflammatory disease.

Place in Management

A balanced management model places night splints within a broader conservative plan. That plan usually includes calf and plantar fascia stretching, load management, footwear advice, and possibly orthoses or other adjunctive treatment depending on the clinical picture. For runners or highly active patients, this integrated approach is especially relevant because symptoms often reflect both tissue irritability and mechanical overload.

From a podiatric perspective, the strongest argument for night splints is that they address a very specific symptom pattern: first-step morning pain. They are less compelling as a universal treatment for every case of heel pain. Therefore, the most accurate academic conclusion is that night splints are a practical, evidence-supported adjunct that may reduce symptoms and improve function, particularly in the short term, but they work best when combined with other conservative measures.

Night splints remain a clinically useful option for plantar fasciitis because they target the overnight shortening that contributes to morning heel pain. The evidence supports their use as part of conservative care, especially in patients with persistent first-step pain, but their benefits are strongest when combined with stretching and other load-reducing strategies. In an essay, the most defensible position is that they are helpful, low-risk, and worth trialling in selected patients, while acknowledging variable comfort and limited long-term superiority.

Posted on

New Balance running shoes

New Balance running shoes are best understood as a broad, performance-led lineup that spans daily trainers, stability models, trail shoes, and race-day supershoes. The brand’s appeal comes from combining cushioning, support, and fit variety with enough range to suit beginners, mileage-focused runners, and competitive athletes alike.

Brand identity

New Balance has long been associated with accommodating fits and practical running performance, especially through its wider size and width options. Its running line evolved from classic numbered models into a modern system built around distinct performance foams and shoe categories, giving runners clearer choices based on use case. That mix of heritage and innovation is one reason the brand remains relevant across recreational and serious running markets

Core technologies

The company’s current running shoes are anchored by a few major midsole platforms. Fresh Foam and Fresh Foam X are positioned as soft, comfortable cushioning systems for daily training and all-day wear, while FuelCell is the more responsive, propulsive option aimed at speed, racing, and lively training runs. New Balance also uses stability features such as medial posts and T-BEAM in some models, plus trail-oriented elements like Vibram outsoles and GORE-TEX uppers in selected shoes.

Model ranges

The neutral daily-trainer segment is led by models such as the 880 and 1080, which are commonly described as reliable high-mileage shoes with comfort-focused rides. The 1080 is presented as a plush but responsive premium trainer, while the 880 is framed as a stable, balanced workhorse for everyday running. For runners needing support, the 860 provides a more structured option with stability-oriented design cues.

At the performance end, New Balance offers FuelCell-based shoes that emphasize speed and rebound. The Rebel line targets lightweight training and faster workouts, while carbon-plated options such as the SuperComp and Elite series are built for race-day efficiency and marathon-level performance. This tiered structure makes the lineup easy to navigate if you know whether you want comfort, support, or race pace

Strengths

One of the strongest points of New Balance running shoes is versatility. The brand produces shoes for easy runs, long runs, tempo sessions, trail running, and racing, so many runners can stay within the same ecosystem across different training needs. Comfort is another recurring strength, with Fresh Foam models especially marketed for soft landings and pressure dispersion.

Fit is also a major advantage. New Balance has built a reputation for offering more accommodating sizing and width choices than many competitors, which is especially valuable for runners who struggle with narrow toe boxes or restrictive uppers. For a lot of runners, that practical fit advantage can matter as much as midsole technology.

Limitations

The main weakness is that the range can feel confusing because many models overlap in purpose. A runner comparing the 880, 1080, More, Rebel, and SuperComp lines may find the differences subtle unless they already understand foam density, stack height, and geometry. Price is another consideration, since premium plated and top-end cushioning shoes often sit at the higher end of the market

Some third-party review sites also show mixed consumer sentiment toward New Balance as a brand, though that reflects broader purchasing and service experiences rather than running performance alone. As with most shoe brands, the best New Balance model depends heavily on the runner’s gait, volume, terrain, and cushioning preference.

Overall assessment

As a running-shoe brand, New Balance stands out for combining comfort, fit options, and a genuinely wide performance spectrum. It is especially strong for runners who want dependable daily trainers, stable mileage shoes, or modern super-shoe performance without leaving the brand ecosystem. If you want a strong general-purpose brand with clear options for neutral, stability, trail, and race use, New Balance is one of the most complete choices on the market.

Posted on

The Neuropad

The assessment of the diabetic foot is fundamentally aimed at identifying patients at risk of ulceration, infection, and amputation before tissue breakdown occurs. Neuropathy is central to that process, because loss of protective sensation, impaired autonomic function, and altered biomechanics all increase plantar loading and reduce the foot’s ability to defend itself. Neuropad has attracted interest because it offers a simple bedside method of detecting one important component of diabetic neuropathy: sudomotor dysfunction. By measuring the skin’s ability to change colour in response to sweat, it provides an indirect marker of sympathetic cholinergic small-fibre function.

Neuropad is applied to the plantar surface of the foot, typically over the great toe or forefoot region, and the result is read after a set period according to the degree and speed of colour change from blue to pink. In healthy skin, the plaster changes colour relatively quickly because sweating is intact. When the colour change is delayed, incomplete, or absent, this suggests reduced sweating and therefore autonomic neuropathy. This mechanism is clinically relevant because autonomic neuropathy contributes to dry, brittle skin and higher vulnerability to cracking and ulceration, especially in patients with diabetes who already have pressure-related risk factors.

The main strength of Neuropad is practicality. It is non-invasive, easy to perform, inexpensive, and does not require advanced equipment or specialised neurophysiology training. These features make it attractive in primary care, podiatry, and other outpatient settings where rapid risk stratification is needed. A meta-analysis of 18 diagnostic studies involving 3470 participants found average sensitivity of 86% and specificity of 65%, supporting its role as a triage test that can help rule out the “foot at risk” when negative. The same review concluded that patients with a positive result should be referred for more specialised assessment to establish a definite diagnosis.

A further advantage is that Neuropad appears to assess small-fibre dysfunction relatively well. In a comparative study of diabetic patients, its accuracy was stronger against corneal nerve fibre length, a marker of small-fibre damage, than against traditional large-fibre tests such as neuropathy disability score, vibration perception threshold, and motor nerve conduction velocity. This matters because early diabetic neuropathy often involves small fibres first, including autonomic fibres, before conventional bedside tests become clearly abnormal. In that sense, Neuropad may detect an earlier stage of neuropathic change than routine large-fibre-focused screening alone.

There is also evidence linking Neuropad to clinical ulcer risk. In one study of type 2 diabetes, the time to complete colour change performed better than 10 g monofilament testing in predicting diabetic foot ulcer risk, with an area under the ROC curve of about 0.8 and a suggested cut-off around 22.25 minutes. This supports the idea that sudomotor impairment is not merely a laboratory marker but has practical value in identifying patients more likely to develop foot complications. Another study in patients with diabetic foot ulceration found that Neuropad was a reliable and easy-to-use test for autonomic neuropathy, which was associated with greater ulceration and amputation risk.

However, Neuropad has important limitations. Its specificity is only moderate, so a positive result does not confirm neuropathy on its own and may produce false positives. It should therefore be interpreted within a full diabetic foot assessment that includes history, inspection, vascular assessment, monofilament or other sensory testing, footwear review, and biomechanical evaluation. The test also does not replace formal neurological examination, and the evidence base has been criticised for risk of bias and uncertainty about patient-important outcomes such as ulcer prevention, cost-effectiveness, and impact on long-term management. For these reasons, Neuropad is best viewed as an adjunctive screening tool rather than a definitive diagnostic test.

In clinical practice, the most defensible use of Neuropad is as part of a layered risk-assessment strategy. A negative result can add reassurance when the overall clinical picture suggests low risk, while an abnormal result can strengthen the case for closer surveillance, patient education, pressure management, and referral for comprehensive neuropathy evaluation. In a podiatry or diabetes clinic, this may be especially useful where there is concern about early autonomic involvement, dry skin, recurrent callus, or unexplained fissuring, all of which can precede ulceration. Its simplicity also makes it attractive for self-testing and community-based screening, although that should not substitute for professional foot surveillance.

Overall, Neuropad has a clear place in the assessment of the diabetic foot as a simple indicator of sudomotor dysfunction and small-fibre neuropathy. Its best role is as a screening or triage tool that helps identify patients needing more detailed evaluation, rather than as a standalone diagnostic endpoint. In an era where diabetic foot complications remain a major cause of morbidity, a test that is quick, non-invasive, and reasonably sensitive can be clinically valuable if used appropriately within a broader assessment framework.[

Posted on

Navicular Stress Fractures

The navicular bone is a key midfoot bone that helps transmit force through the medial arch during gait, running, sprinting, and jumping. Because it sits between the talus and cuneiforms, it is subjected to repetitive compression and bending forces, which helps explain why stress injury can develop even without a single traumatic event. Navicular stress fractures are considered important in sports medicine and podiatry because they often present subtly at first but can progress if the athlete continues loading the foot.

A navicular stress fracture usually begins as a stress reaction and then progresses to a crack in the bone if repetitive stress continues. The condition is most commonly associated with running and jumping sports, including track and field, soccer, gymnastics, and similar high-impact activities. Risk factors described in the literature include repetitive impact, reduced ankle dorsiflexion, excessive pronation, and possibly footwear or training changes that alter load across the midfoot. For a clinical audience, it is worth noting that the navicular’s relatively poor blood supply contributes to delayed healing and makes the injury more concerning than many other stress fractures.

Clinically, patients often report vague pain in the middle or inner arch of the foot rather than a clearly localized acute injury. Pain may initially appear only during running or jumping, then gradually become more persistent and may even occur with walking or at rest if the injury worsens. Tenderness over the navicular region, pain with hopping or toe-rise, swelling, bruising, and a limping gait may all be present, although findings can be subtle. Because symptoms are often nonspecific, navicular stress fractures are commonly missed or mistaken for soft tissue or tendon pathology.

Diagnosis depends on maintaining a high index of suspicion, especially in athletes with midfoot pain that worsens with impact activity. Plain radiographs may not show the injury early, so advanced imaging such as CT, MRI, or bone scan may be needed when suspicion remains high. CT is particularly useful for defining the extent and severity of the fracture, while MRI and bone scan can help identify early stress injury before a complete fracture line is obvious. In an essay, this is a good place to emphasize that delayed diagnosis is a major reason navicular stress fractures become prolonged and difficult to manage.

Treatment is usually conservative at first, but it must be strict and adequately protective. Typical management involves immediate cessation of impact activity, non-weight-bearing immobilization in a cast or boot, and gradual rehabilitation only after pain and tenderness resolve. Some sources describe a minimum non-weight-bearing period of about six weeks, with progression based on symptoms and follow-up assessment. If healing is incomplete, or if the fracture is severe, displaced, or fails to improve, surgery may be considered, usually involving screw fixation and occasionally bone grafting.

Rehabilitation should address not only bone healing but also the contributing mechanics that may have overloaded the navicular in the first place. This can include calf flexibility work, gait or running analysis, correction of training errors, and orthotic intervention when indicated to reduce midfoot stress. A graded return to sport is essential, because symptom improvement alone does not always mean the fracture is healed. In practice, premature return to running is a major reason for recurrence or prolonged pain.

The prognosis depends heavily on early recognition and adherence to treatment. When treated appropriately, many patients recover well, but navicular stress fractures are still regarded as high risk because delayed union, nonunion, and chronic midfoot pain can occur if the injury is ignored or under-treated. For athletes, the injury can be season-ending or even career-threatening in severe cases, which is why many authors stress prompt imaging and strict offloading. In a concluding paragraph, you can frame the navicular stress fracture as a classic example of how biomechanics, training load, bone vascularity, and early diagnosis intersect in sports podiatry.

Navicular stress fractures are best understood as a serious overuse injury of the midfoot with vague early symptoms, high diagnostic miss rates, and a meaningful risk of delayed healing. An effective essay should highlight the biomechanics of the navicular, the athlete profile at risk, the need for advanced imaging, and the importance of strict non-weight-bearing management before gradual return to sport.

Posted on

Navicular Drop Test

The Navicular Drop test is a widely used clinical assessment in podiatry, physiotherapy, sports medicine, and biomechanics. It is designed to quantify the change in height of the navicular tuberosity between a subtalar joint neutral position and a relaxed weight-bearing position. In practice, the test is often used as an indirect marker of pronation, medial longitudinal arch collapse, and foot mobility. Although it is simple to perform and has practical value in clinical settings, its interpretation must be cautious, as the test is only one component of a broader musculoskeletal assessment.

The test was originally described by Brody in 1982 as a way to assess pronation in runners. Since then, it has been incorporated into routine foot and lower-limb examination because of its ease of use, low cost, and minimal equipment requirements. Clinicians typically use a ruler, pen, and a stable surface to measure the vertical displacement of the navicular tuberosity. The result is reported in millimetres, and a larger drop is generally interpreted as greater foot mobility or reduced arch control. In many teaching and clinical resources, a navicular drop greater than about 10 mm is considered suggestive of excessive pronation or arch collapse, although thresholds vary across studies and populations.

The procedure begins by identifying and marking the most prominent part of the navicular tuberosity. The patient is positioned so that the subtalar joint is placed in neutral, usually in a non-weight-bearing or partially supported posture. The clinician then measures the distance from the navicular marker to the floor or another fixed reference point. The patient is then asked to stand in a relaxed, weight-bearing position, and the measurement is repeated. The difference between the two values is the navicular drop. Some clinicians use slight variations in positioning, including a seated-start version or a single-leg stance version, but the core principle remains the same: quantify how much the navicular descends when load is applied.

One of the main reasons the Navicular Drop test is popular is that it provides a quick estimate of medial longitudinal arch behaviour. The navicular bone sits near the midpoint of the arch, so changes in its height reflect motion occurring through the midfoot and rearfoot complex. A larger drop may indicate greater subtalar joint pronation and a more mobile or less supported arch structure. This is clinically relevant because excessive or prolonged pronation has often been associated with overuse problems such as plantar heel pain, medial tibial stress syndrome, and patellofemoral pain, although causation is not straightforward and should not be assumed from one measure alone. In runners, the test has also been used in screening contexts to identify individuals who may require footwear, load management, or orthotic considerations.

Despite its popularity, the Navicular Drop test has limitations. A major issue is that it does not directly measure pronation in all of its components; rather, it captures one aspect of foot motion in the sagittal plane. Pronation is a multiplanar movement involving eversion, abduction, and dorsiflexion, so navicular drop should not be treated as a complete representation of foot mechanics. In addition, measurement reliability can be affected by examiner skill, palpation accuracy, patient posture, and consistency in locating the navicular tuberosity. These sources of error are important because even small differences in landmark identification can change the result.

The evidence on reliability and validity is mixed but generally supports the test as a practical clinical tool. One study reported that the Navicular Drop test appears to be reproducible, valid, and simple for evaluating medial longitudinal arch height, with fewer disadvantages than footprint-based measures. Other studies have described it as a composite measure of excessive pronation, while also noting that it is better used as part of a broader assessment rather than as a definitive diagnosis. This means that the test has value, but its findings should be interpreted alongside history, observation, joint range of motion, muscle function, footwear assessment, and symptom behaviour.

In clinical reasoning, the test is most useful when it helps answer a specific question. For example, in a runner with recurrent medial shin pain, a high navicular drop may support the suspicion of a mobile pronated foot posture contributing to load distribution. In a patient with plantar heel pain, it may help identify excessive midfoot mobility that could be relevant to tissue strain. In a paediatric or adolescent population, it may assist in documenting arch development over time. However, a high navicular drop does not automatically mean pathology, and a low value does not guarantee normal function. Foot structure and movement vary widely between healthy individuals, and some degree of pronation is normal and necessary for shock absorption and adaptation.

The test is also useful because it is easy to repeat and can be used to monitor change over time. For example, it may help document the effect of orthotic therapy, exercise therapy, taping, or footwear changes on foot posture. If a patient’s navicular drop decreases after an intervention, that may suggest improved arch support or altered foot mechanics, though clinical outcomes and symptoms remain more important than the number alone. This makes the test particularly valuable in evidence-informed practice, where objective measures complement symptom-based assessment.

The Navicular Drop test is a practical, low-cost method for estimating arch mobility and pronation-related foot behaviour. It is easy to administer, useful for screening and monitoring, and familiar to clinicians working in foot and lower-limb biomechanics. Its greatest strength is simplicity, but that simplicity is also its weakness, because the test captures only one part of a complex movement pattern. For that reason, it should be interpreted cautiously and always integrated with the rest of the clinical examination. Used appropriately, the Navicular Drop test remains a valuable tool in podiatry and sports medicine, especially when the goal is to understand how foot structure and function may relate to symptoms, load, and movement.

Posted on

Midfoot osteoarthritis

is a common but often under-recognized cause of pain on the top and middle of the foot, especially in middle-aged and older adults. It affects the joints that support the arch—most often the tarsometatarsal, naviculocuneiform, and talonavicular joints—and can lead to pain, altered foot shape, and difficulty with walking and standing.

Midfoot osteoarthritis

Midfoot osteoarthritis (OA) refers to degenerative change in one or more joints of the midfoot, the region between the hindfoot and forefoot. The midfoot has relatively limited motion under normal conditions, but it plays an essential role in load transfer, arch support, and foot stability during gait. When osteoarthritis develops, the articular cartilage deteriorates, the joint surfaces become irregular, and the surrounding bone responds with sclerosis and osteophyte formation.

Although midfoot OA can occur as primary idiopathic disease, it is also associated with previous injury, chronic abnormal loading, flatfoot posture, obesity, manual work, and other weight-bearing joint pain. Symptomatic disease is more common with increasing age and is reported particularly in women and people with a history of foot or ankle trauma.

Clinical features

The typical presentation is dorsal or central midfoot pain that worsens with walking, standing, stairs, or prolonged activity. Patients often report swelling, tenderness over the affected joints, and a bony prominence on the top of the foot. Morning stiffness may occur, but in the midfoot the more prominent complaint is usually load-related pain rather than a dramatic loss of motion.

As the condition advances, the arch may flatten and the foot may appear broader or more collapsed, especially if the condition is associated with pronation or progressive midfoot instability. Symptoms can range from mild intermittent discomfort to constant pain that interferes with work, exercise, and routine daily tasks

Diagnosis

Diagnosis begins with a careful history and physical examination, focusing on pain location, aggravating activities, deformity, swelling, and tenderness over the tarsometatarsal and naviculocuneiform joints. Plain radiographs are usually the first imaging test and may show joint-space narrowing, dorsal osteophytes, subchondral sclerosis, and collapse or malalignment in more advanced disease.

When the diagnosis is uncertain or surgery is being considered, additional imaging such as weight-bearing radiographs, CT, MRI, or diagnostic injections may help identify the exact joints involved and the degree of arthritic change. This is especially useful in the midfoot because pain can arise from more than one joint and clinical localization can be imperfect.

Non-surgical care

Initial treatment is usually non-operative and aims to reduce joint load, calm inflammation, and preserve function. Common measures include activity modification, weight management, analgesics or anti-inflammatory medication, footwear changes, stiff-soled shoes or rocker-bottom soles, and orthoses that support the medial arch and limit painful midfoot motion.

Orthotic treatment is often central because the midfoot is a load-sharing structure and reducing movement across arthritic joints can significantly improve symptoms. In practice, this may include arch-supporting devices, stiff shank modifications, and foot orthoses designed to improve alignment and distribute pressure more evenly. Calf stretching and physiotherapy may also help in selected patients, particularly where equinus or altered mechanics contribute to excessive midfoot loading.

Corticosteroid injection may be used for short-term symptom relief, especially when one or two joints are clearly symptomatic. Injections can also have diagnostic value by confirming the pain generator before a more definitive procedure is planned.

Surgical treatment

Surgery is considered when pain remains disabling despite appropriate conservative care or when deformity and collapse are progressing. The main surgical option for advanced disease is arthrodesis, or fusion, of the affected midfoot joints to remove painful motion and restore alignment.

Fusion is generally most useful in patients with localized arthritic pain, structural collapse, or a painful deformity that cannot be controlled with footwear and orthoses. In milder cases with prominent dorsal osteophytes but limited joint destruction, debridement or spur excision may be considered, though this does not reverse arthritis. The choice of operation depends on the joints involved, the degree of deformity, activity demands, and bone quality.

Functional impact

Midfoot OA can have a major effect on quality of life because the foot is exposed to high repetitive loads with every step. Pain may limit walking distance, reduce participation in sport and exercise, and make occupational standing difficult. The condition can also alter gait and load transfer to adjacent joints, potentially contributing to compensatory problems elsewhere in the foot or lower limb.

A useful way to think about the condition is that the patient often does not complain of “stiffness” in the classic arthritic sense, because the midfoot is already relatively stiff. Instead, they notice pain from the top of the foot, aching in the arch, swelling, or a change in foot shape that signals structural failure under load.

Midfoot osteoarthritis is a disabling degenerative condition involving the joints that support the arch and transfer load through the foot. Its hallmark features are activity-related midfoot pain, dorsal tenderness or bony prominence, and sometimes progressive flattening of the arch

Management should begin with careful diagnosis and staged conservative treatment, particularly footwear modification and arch-supporting orthoses, with injections or fusion reserved for persistent or advanced cases. Because the midfoot is biomechanically central to gait, successful treatment depends on addressing both pain and load redistribution rather than simply treating inflammation.

Posted on

How can menopause affect the feet?

Menopause can affect the foot in several interconnected ways, mainly through hormonal shifts that alter connective tissue, bone health, skin hydration, body weight, and pain sensitivity. A good essay on this topic should show that foot symptoms are not just local problems; they often reflect wider musculoskeletal and metabolic changes that occur during the menopausal transition.

Menopause is a natural stage of life marked by the decline of ovarian hormones, especially oestrogen and progesterone. These hormonal changes can influence many body systems, including the feet, where women may notice new pain, stiffness, dryness, or changes in foot shape. Although foot complaints are often not the first symptom associated with menopause, they can be clinically important because they affect mobility, comfort, and activity levels.

Hormonal Effects

Oestrogen has a role in maintaining collagen production, tissue elasticity, and musculoskeletal integrity, so declining levels may reduce the resilience of structures in the foot. As connective tissue becomes less elastic, the plantar fascia, tendons, and ligaments may tolerate load less effectively, which can contribute to pain and overuse symptoms. Some sources also note that lower oestrogen may affect blood vessels and temperature regulation, which can alter how the feet feel, including burning or hot feet.

Structural Changes

One of the most relevant mechanisms is the gradual loss of soft-tissue support in the foot. Reduced collagen and tissue quality may contribute to arch changes, reduced cushioning under the heel and forefoot, and greater strain during standing and walking. This can make the feet feel more tired or sore after ordinary activity, especially in women who are already on their feet for long periods. In some cases, these changes may also worsen existing deformities such as bunions or increase pressure-related problems like corns and calluses.

Common Foot Problems

Several foot conditions are reported more often or become more noticeable during menopause. Plantar fasciitis is commonly mentioned because the plantar fascia may become less adaptable to repetitive stress as oestrogen declines. Other problems include bunions, stiff or painful big toe joints, Achilles or other tendon pain, neuroma-type forefoot pain, and stress fractures when bone density is reduced. These issues may not be caused by menopause alone, but menopause can increase susceptibility by weakening the supporting tissues.

Skin And Nails

Menopausal hormonal changes can also affect the skin of the feet. Reduced moisture retention may lead to dry skin and cracked heels, which can become painful and in some cases infected. Thinner, drier skin may also increase the formation of callus because the skin is less able to adapt to pressure and friction. Nail changes may occur as well, with some women noticing brittleness or increased vulnerability to fungal infection.

Weight, Activity, And Pain

Menopause is often associated with changes in body composition and activity patterns, and both can affect foot load. Even small weight gains can increase pressure under the heel and forefoot, which may aggravate pain, callus, and fatigue. Reduced activity due to fatigue, mood change, or hot flushes may also lead to muscle weakness, stiffness, and poorer foot and ankle conditioning. This creates a cycle in which discomfort reduces movement, and reduced movement then contributes to more discomfort.

Bone And Nerve Health

The menopausal drop in oestrogen is also important for bone health. Lower bone mineral density can increase the risk of stress fractures in the small bones of the foot, especially when repetitive loading is combined with reduced cushioning or altered mechanics. In addition, some women report burning feet or altered sensation, which may reflect changes in circulation, temperature regulation, or broader health issues that become more common with age. Because neuropathy, diabetes, and arthritis may coexist in midlife and later life, foot symptoms during menopause should not be assumed to be purely hormonal.

Clinical Significance

For clinicians, the key point is that menopausal foot complaints deserve the same careful assessment as any other musculoskeletal problem. A history should include onset, location of pain, shoe changes, activity level, weight changes, skin integrity, and risk factors such as diabetes or osteoporosis. Management may include education, footwear modification, load management, calf and foot strengthening, treatment of dry skin, and specific interventions for plantar fasciitis, bunions, or other diagnosed conditions. Early recognition matters because small changes in tissue quality and load tolerance can become chronic if not addressed.

Menopause can affect the foot through a combination of hormonal, structural, metabolic, and skin-related changes. The most important consequences are pain, reduced cushioning, altered arch mechanics, dry and cracked skin, and greater vulnerability to overuse or bone stress injury. A strong essay should emphasise that these symptoms are common, often under-recognised, and clinically meaningful because they can reduce mobility and quality of life.

Posted on

Mueller Weiss syndrome of the Navicular

Mueller Weiss syndrome is a rare, progressive adult foot disorder affecting the navicular bone in the midfoot, often causing chronic medial midfoot and hindfoot pain, arch collapse, and deformity. It typically affects adults in the 40 to 60 age range and is more common in women, and it is often misdiagnosed because its symptoms overlap with other causes of midfoot pain.

Mueller Weiss syndrome, also called Müller-Weiss syndrome or Brailsford disease, is an uncommon condition characterized by spontaneous osteonecrosis and deformity of the tarsal navicular bone in adults. The navicular sits at the top of the medial longitudinal arch and plays a central role in force transmission through the midfoot, so structural failure in this bone can have major biomechanical consequences. Although the exact cause remains uncertain, the condition is widely understood as multifactorial, with proposed contributions from abnormal loading, congenital navicular dysplasia, ischemia, and prior trauma.

Pathology and causes

The defining feature of the syndrome is progressive collapse and fragmentation of the navicular, usually beginning later in life rather than in childhood. This distinguishes it from Köhler disease, which is navicular osteochondrosis in children. In adult disease, the navicular may become compressed, flattened, and laterally collapsed, producing the classic “comma-shaped” appearance on imaging. Some authors describe the process as spontaneous osteonecrosis, while others emphasize a combination of dysplasia, mechanical overload, and degenerative change.

Clinical presentation

Patients usually present with insidious medial midfoot pain, often accompanied by hindfoot pain, stiffness, and difficulty walking or standing for long periods. The deformity may be bilateral, though it can be asymmetric, and pes planovarus or progressive flattening of the arch is common. Tenderness over the navicular region, reduced midfoot motion, and pain with weight-bearing are typical findings. Because onset is gradual and symptoms are nonspecific, the disorder can be mistaken for posterior tibial tendon dysfunction, midfoot arthritis, stress fracture, or nonspecific flatfoot pain.

Imaging findings

Radiography is usually the first and most useful investigation, showing collapse of the lateral navicular with medial or dorsal extrusion of part of the bone or the whole navicular. CT can better define sclerosis, fragmentation, and the degree of collapse, while MRI is valuable for early disease because it detects marrow edema and other signal changes. Imaging also helps stage severity and guide treatment planning, especially when surgical reconstruction is being considered. In advanced cases, adjacent joints may show degenerative change as the deformity alters midfoot mechanics.

Management

Initial treatment is usually conservative and focuses on reducing pain and mechanical stress across the midfoot. This may include activity modification, analgesics or anti-inflammatory medication, custom orthotics, supportive footwear, bracing, and sometimes immobilization. These measures aim to offload the navicular, support the arch, and reduce symptoms, but they do not reverse the deformity. If symptoms remain severe or deformity progresses, surgery may be necessary, often involving fusion procedures such as talonavicular or talonavicular-cuneiform arthrodesis, sometimes combined with bone grafting.

Prognosis and significance

The prognosis depends largely on the stage at diagnosis and the severity of collapse and arthritis. Some patients respond reasonably well to conservative care, but others develop persistent pain and disability that affect mobility and quality of life. Because the condition is uncommon and easy to miss, delayed diagnosis is a major problem; by the time it is recognized, structural damage may already be advanced. For that reason, Mueller Weiss syndrome should be considered in adults with chronic midfoot pain, especially when imaging shows navicular deformity and arch collapse.

Mueller Weiss syndrome is an important but under-recognized cause of adult midfoot pain caused by progressive navicular collapse and deformity. Its clinical importance lies in its tendency to mimic more common foot disorders while steadily worsening if not properly identified. Early recognition, appropriate imaging, and staged treatment can reduce pain, preserve function, and help prevent progression to severe midfoot arthritis and deformity.

Posted on

Mycetoma affecting the foot

Mycetoma affecting the foot is a chronic, progressively destructive infection that usually begins after traumatic implantation of bacteria or fungi into skin and soft tissue. It commonly presents with a painless swelling of the foot, sinus tracts that drain pus, and visible “grains” in the discharge, and if diagnosis is delayed it can invade bone and lead to severe deformity or amputation

Mycetoma is an important tropical and subtropical disease because it often affects people who work barefoot in rural environments and may not seek care until the disease is advanced. The foot is the classic site of infection, likely because it is frequently exposed to thorn pricks, splinters, and other minor penetrating injuries that introduce organisms from soil or plant matter into deeper tissues. Although the disease is not common in many parts of the world, it has major consequences for mobility, work capacity, and quality of life. For a condition that often starts quietly, its later effects can be devastating.

Cause and transmission

Mycetoma is caused by either bacteria or fungi, which leads to two broad forms: actinomycetoma and eumycetoma. The organisms are usually environmental, living in soil, water, or plant material, and infection typically follows a break in the skin rather than person-to-person spread. Minor injuries such as stepping on a thorn or wood splinter are classic triggers, especially in settings where shoes are not regularly worn. The disease is therefore closely tied to occupation, poverty, and limited access to preventive footwear and healthcare. This makes mycetoma more than an infection; it is also a marker of social vulnerability.

Clinical features

The hallmark of foot mycetoma is a slowly enlarging, usually painless swelling that may persist for months or years before diagnosis. Over time, the lesion can develop multiple draining sinuses that discharge thick material containing tiny grains, which may be white, yellow, red, brown, or black depending on the causative organism. Because pain is often minimal, many patients continue walking and working while the lesion gradually expands. As the disease progresses, the foot may become distorted, stiff, or functionally unusable, and secondary bacterial infection can complicate the picture. In advanced cases, underlying muscle, tendons, and bone may be destroyed.

Diagnosis

Diagnosis of foot mycetoma depends on a combination of clinical suspicion, imaging, and laboratory confirmation. A careful history of barefoot exposure, thorn injury, rural work, and very slow progression should raise suspicion early. Imaging such as ultrasound or X-ray can help assess the extent of soft tissue involvement and detect bone invasion, while biopsy, aspiration, or examination of the grains can identify the organism. This distinction matters because actinomycetoma and eumycetoma require different treatment approaches. Delayed diagnosis is common because the condition may mimic chronic abscesses, osteomyelitis, or other granulomatous foot disorders.

Treatment

Treatment depends on whether the infection is bacterial or fungal. Actinomycetoma usually responds better to prolonged antibiotic therapy, while eumycetoma generally requires long-term antifungal treatment, often with itraconazole or related agents. Surgery may be needed when there is extensive local disease, failure of medical therapy, or significant bone involvement. In late or severe cases, bone resection or even amputation may be required to control the infection and preserve overall function. Because treatment is prolonged and relapses can occur, adherence and follow-up are essential. Outcomes are best when the disease is caught before major tissue destruction has occurred.

Public health impact

Foot mycetoma has a disproportionate effect on people in endemic regions of Africa, Latin America, and Asia, especially farmers, herders, and other outdoor workers. The disease can cause long-term disability, lost income, and stigma, particularly when deformity becomes visible. Prevention is therefore straightforward in principle but difficult in practice: wearing protective shoes, promptly cleaning wounds, and seeking early evaluation after penetrating foot injuries can reduce risk. However, these measures are harder to implement where poverty, remote geography, and limited healthcare access persist. This is one reason mycetoma is recognized as a neglected tropical disease

Conclusion

Mycetoma of the foot is a chronic infection that begins innocently but can become highly destructive if not recognized early. Its classic triad of painless swelling, draining sinuses, and grains in discharge should prompt urgent evaluation, especially in people from endemic regions or those with barefoot exposure. Because treatment differs for bacterial and fungal disease, accurate diagnosis is critical, and early therapy offers the best chance of preventing deformity, disability, and amputation. In clinical practice, the key challenge is not just treating mycetoma, but diagnosing it before the foot is irreversibly damaged.

Posted on

Treatment of Morton’s Neuroma

Morton’s neuroma is a painful condition caused by thickening and irritation of a nerve in the forefoot, most often between the third and fourth toes. It commonly feels like walking on a pebble, with burning, stabbing, tingling, or numbness in the ball of the foot, and symptoms are often worsened by tight shoes, high heels, or repetitive forefoot loading such as running.

Morton’s Neuroma in the Foot

Morton’s neuroma is a compressive neuropathy affecting the interdigital nerve, usually in the third intermetatarsal space and less commonly in the second. Although it is called a neuroma, it is not a true tumour; rather, it is a fibrotic enlargement and irritation of the nerve caused by chronic pressure or traction. The condition is most often discussed in relation to female patients and people who frequently wear narrow or high-heeled footwear, though it can occur in anyone exposed to repetitive forefoot stress

Causes and Risk Factors

The exact cause of a Morton Neuroma is not always clear, but the condition is strongly associated with mechanical compression of the nerve. Tight toe boxes, pointy shoes, and high heels increase pressure across the forefoot, while running and other high-impact activities can repeatedly irritate the nerve. Foot structure also matters: bunions, hammertoes, flat feet, and high arches may alter load distribution and contribute to nerve irritation.

Symptoms and Clinical Features

The classic symptom of a Morton’s neuroma is sharp or burning pain in the ball of the foot, usually radiating into the adjacent toes. Many people describe a sensation of “walking on a marble” or having a stone stuck under the foot. Tingling, numbness, or pain that increases when standing, walking, or wearing restrictive shoes is also common.

Diagnosis

Diagnosis is usually clinical, based on the history and location of pain. A clinician may reproduce symptoms by squeezing the forefoot or by palpating the affected web space, and imaging such as ultrasound or MRI can be used when the diagnosis is unclear or when other conditions need to be excluded. Because forefoot pain can also come from metatarsalgia, stress fracture, plantar plate injury, or intermetatarsal bursitis, a careful differential diagnosis is important.

Conservative Treatment

Initial treatment is usually non-surgical. The most important step is reducing pressure on the nerve by switching to wide, supportive shoes with a low heel and soft sole, and by avoiding tight or pointy footwear. Padding, soft insoles, activity modification, and reducing running or jumping may also ease symptoms. If pain persists, corticosteroid injections, custom orthoses, or other specialist treatments may be considered.

Surgical Management

Surgery is generally reserved for persistent cases that do not respond to conservative care. The main procedures are decompression of the nerve or excision of the affected nerve segment, and both can provide good pain relief in selected patients. A key trade-off is postoperative numbness in the toes supplied by the removed or released nerve, which patients should understand before deciding on surgery.

Morton’s neuroma is a common and often frustrating cause of forefoot pain, but it is usually manageable once correctly identified. Because symptoms are closely linked to shoe choice and loading patterns, early treatment often focuses on reducing compression and improving foot mechanics. For persistent cases, injections or surgery may be needed, but many patients improve with appropriately targeted conservative care.